DIVISLAB.NS

Divi's Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$18.70B

PE Ratio

59.35

EV to Ebitda

—

Earnings Yield

2.00%

Revenue (TTM)

$1.07B

Net Income (TTM)

$315.1M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

12.00%

Profit Margin

24.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$18.70B

Revenue TTM$1.07B

Shares Outstanding265.5M

Float127612275

Insider Ownership52.00%

Institutional Ownership29.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)12.00%

Rev Growth Est 1Y Forward0.16

EPS Growth (Quarterly YoY)-1.00%

EPS Growth Est Quarterly23.28

LT EPS Growth Estimates21.00%

EBITDA Growth (Quarterly YoY)10.00%

Operations19 fields›

Revenue TTM$1.07B

Gross Margin TTM62.00%

Gross Margin (Quarterly)64.00%

Operating Margin TTM30.00%

Operating Margin (Quarterly)30.00%

Operating Expenses TTM$1.9M

Profit Margin TTM24.00%

Profit Margin (Quarterly)22.00%

Net Income TTM$315.1M

EPS TTM93.28

EPS (Quarterly)21.96

EBITDA Margin TTM33.00%

EBITDA Margin (Quarterly)35.00%

EBITDA TTM$350.4M

CFO TTM$85.3M

Capex % of Revenue TTM29.00%

Capital Expenditures$310.7M

FCF % of Revenue (Quarterly)5.00%

FCF TTM$85.3M

Efficiency1 fields›

ROA10.00%

Valuation5 fields›

P/E (TTM)59.35

P/E Forward19.57

EV/Revenues (TTM)17

Earnings Yield2.00%

Payout Ratio43.00%

Liquidity5 fields›

Cash Per Share139.94

Current Ratio6.94

Total Assets$2.00B

Shareholders Equity$1.70B

Interest Expense$1.9M

Yields3 fields›

Payout Ratio43.00%

Earnings Yield2.00%

Buyback Yield0.00%